Search

Author/Creator Wang, HanChen

5. Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study. (February 2022)

Authors:
Farge, Dominique; Loisel, Séverine; Resche-Rigon, Matthieu; Lansiaux, Pauline; Colmegna, Ines; Langlais, David; Charles, Catney; Pugnet, Grégory; Maria, Alexandre Thibault Jacques; Chatelus, Emmanuel; Martin, Thierry; Hachulla, Eric; Kheav, Vissal David; Lambert, Nathalie C; Wang, HanChen; Michon...
Journal:
Lancet
Issue:
Volume 4:Number 2(2022)
Page Start:
e91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗